Clinical trial
BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients
NCT06439069 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients
- Lead sponsor
- Lithuanian University of Health Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 10, 2023
- Completion date
- December 1, 2024
- Enrollment
- 340 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.